List your company on Longevity Club — free.

Put your products in front of thousands of active longevity customers.

Claim free listing

Glycominds For Profit

IBDX® is the most validated and cost-effective serological panel to aid in the differential diagnosis of IBD vs. non-IBD and for CD vs. UC, as well as for predicting the probability of Crohn's Disease progression.

Technology: Biomarker panels
Headquarters: Lod, HaMerkaz, Israel
Funding Status: N/A
Investment Stage: N/A
Investor Type: N/A
Estimated Revenue: $1.4Mper year
Employee Number: 11-50
Industry: Clinical Data Management
Number Of Exists: N/A
Founded Date: 1999-01-01